#ALS AWARENESS #L...
Follow
Find tag "NurOwn"
111.5K views | +19 today
#ALS AWARENESS #LouGehrigsDisease #PARKINSONS
Raising ALS | Lou Gehrigs Disease & Parkinsons Disease AWARENESS to the NEXT LEVEL!
Your new post is loading...
Your new post is loading...
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

BrainStorm’s NurOwn Stem Cell ALS Therapy Designated “Fast-track” Product

BrainStorm’s NurOwn Stem Cell ALS Therapy Designated “Fast-track” Product | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
Amyotrophic lateral sclerosis (ALS) is a devastating neuromuscular disease that progresses swiftly, causing motor neuron degeneration and subsequent muscle
more...
No comment yet.
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

BrainStorm Signs Definitive Agreement with Mayo Clinic for ALS Clinical Trial and NurOwn Manufacturing

BrainStorm Signs Definitive Agreement with Mayo Clinic for ALS Clinical Trial and NurOwn Manufacturing | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it

BrainStorm Cell Therapeutics (OTCQB: BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, announced today that it has signed a definitive agreement with the Mayo Clinic in Rochester, Minnesota to conduct its Phase II clinical trial of NurOwn(TM) in amyotrophic lateral sclerosis (ALS), pending FDA approval. In addition, Mayo's Human Cell Therapy Laboratory will ...........

more...
No comment yet.
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in
the European Union for ALS

BrainStorm's NurOwn Cell Therapy Receives Orphan Drug Designation in<br/>the European Union for ALS | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it

BrainStorm Cell Therapeutics (otcqb:BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the European Commission has granted Orphan Drug Designation for NurOwn(TM), the Company's stem cell therapy consisting of autologous bone marrow-derived mesenchymal stromal cells secreting neurotrophic factors, for the treatment of Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's Disease. NurOwn received Orphan Drug Designation from the............

more...
No comment yet.
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

Stem Cell Therapy For ALS Appears Safe, Well-Tolerated

Stem Cell Therapy For ALS Appears Safe, Well-Tolerated | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
TEL AVIV, July 23 (Reuters) - A clinical trial of ALS patients conducted by BrainStorm Cell Therapeutics shows its adult stem cell therapy is well-tolerated, appears to be safe and does not present undue risk,...
more...
No comment yet.
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

FDA Grants Fast Track Designation to NurOwn for the Treatment of ALS

FDA Grants Fast Track Designation to NurOwn for the Treatment of ALS | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
BrainStorm Cell Therapeutics Inc., a leading developer of adult stem cell technologies for neurodegenerative diseases, announced that the United States Food and Drug Administration (FDA) has designated NurOwn as a Fast Track product for the treatment of amyotrophic lateral sclerosis (ALS, or Lou Gehrig's Disease).
more...
No comment yet.
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

ALS Patient Improves On NurOwn, New Stem Cell Therapy; Company Awaits FDA Decision For Phase II Trial

ALS Patient Improves On NurOwn, New Stem Cell Therapy; Company Awaits FDA Decision For Phase II Trial | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
An individual diagnosed with both ALS and MG showed improvements in cognitive and motor function following initial and repeat treatments with NurOwn, a new stem cell treatment.
more...
No comment yet.
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

Brainstorm Cell Therapeutics Inc : BrainStorm and Octane to Develop Revolutionary Bioreactor-Based NurOwn Stem Cells Production Process

Brainstorm Cell Therapeutics Inc : BrainStorm and Octane to Develop Revolutionary Bioreactor-Based NurOwn Stem Cells Production Process | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it
BrainStorm Cell Therapeutics , a leading developer of
adult stem cell technologies for neurodegenerative diseases, announced
today that it has signed an agreement with Octane.

BrainStorm is currently conducting a Phase I/II clinical trial in ALS patients at the Hadassah Medical Center in Jerusalem and is planning to expand its clinical development in the USA, pending FDA approval. Towards that goal, the Company has entered into a Memorandum of Understanding with the University of Massachusetts Medical School and Massachusetts General Hospital to begin ALS human clinical trials at these institutions.
more...
No comment yet.
Scooped by TEAM Mike Lopez Memorial Foundation |Find us on Twitter:@TEAMCUREALS
Scoop.it!

Israel & U.S. ALS Clinical Trials

Israel & U.S. ALS Clinical Trials | #ALS AWARENESS #LouGehrigsDisease #PARKINSONS | Scoop.it

Brainstorm is running a Phase I/II clinical trial with NurOwn™ ,BrainStorm’s autologous stem cell therapy for people with Amyotrophic Lateral Sclerosis (ALS often referred to as Lou Gehrig's Disease).

more...
No comment yet.